About Actavis

• Company Profile
• CEO Message
• Mission / Culture
• Executive Leadership
• Global Locations
  • Facilities
  • Commercial
  • Americas
  • Europe
  • Asia Pacific

Global Business

• Distribution
  • Anda
  • PractRx
  • Intellogics
• Actavis Pharma
  • North America
  • Europe
  • Asia & MEA
• Actavis Specialty Brands
  • United States
  • Canada & LATAM
  • Biosimilars

Products

• Drug Safety
• R&D
  • R&D Sites
  • Generics R&D
  • Biosimilars R&D
  • Brands R&D
• Quality
• Therapeutic Classes
  • Generics
  • Biosimilars
  • Brands
• U.S. Product Database

Investors

• Press Releases
• Financial Information
  • SEC Filings
  • Annual Reports
  • Quarterly Results
  • 2013 Proxy Materials
  • Corporate Fact Sheet
• Corporate Governance
  • Executive Officers and Directors
  • Committee Composition
  • Committee Charters
  • Code of Conduct
  • Governance Guidelines
  • Insider Transactions
  • Actavis Compliance Program
• Events and Presentations
• Stock Information
  • Stock Quote
  • Stock Chart
  • Historical Price Lookup
  • Investment Calculator
• Shareholder Services
  • FAQs
  • Information Requests
  • E-mail Alerts
• Analyst Coverage

Responsibility

• Environmental
  • Employees
  • Facilities & Manufacturing
  • Partners
• Community

Media

• Corporate Profile
• Press releases
• Resources
• Warner Chilcott Acquisition

Careers

• Working at Actavis
  • Culture
  • Benefits
• University
  • On-Campus Recruiting
  • Internships & Programs
  • Recent Graduates
  • Applying to Actavis in the US
• Career Opportunities

Contact Us